PharmaResearch Co., Ltd. (KOSDAQ: 214450)
184,600
-3,700 (-1.96%)
Sep 11, 2024, 9:00 AM KST
PharmaResearch Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2015 |
---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 10, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2015 |
Market Capitalization | 1,909,539 | 1,116,952 | 697,316 | 818,025 | 552,155 | 343,774 | Upgrade
|
Market Cap Growth | 5.17% | 60.18% | -14.76% | 48.15% | 60.62% | 7.92% | Upgrade
|
Enterprise Value | 1,766,873 | 990,868 | 612,568 | 761,136 | 536,011 | 317,055 | Upgrade
|
Last Close Price | 184600.00 | 109500.00 | 69286.84 | 80515.43 | 55760.85 | 35180.89 | Upgrade
|
PE Ratio | 22.30 | 14.60 | 17.04 | 17.08 | 16.18 | 19.92 | Upgrade
|
PS Ratio | 6.36 | 4.28 | 3.58 | 5.31 | 5.08 | 4.10 | Upgrade
|
PB Ratio | 3.95 | 2.42 | 1.88 | 2.49 | 2.09 | 1.50 | Upgrade
|
P/FCF Ratio | 24.11 | 21.12 | 16.54 | 18.32 | -230.71 | 35.49 | Upgrade
|
P/OCF Ratio | 14.69 | 17.20 | 11.74 | 12.53 | 17.05 | 17.84 | Upgrade
|
EV/Sales Ratio | 5.96 | 3.80 | 3.15 | 4.94 | 4.93 | 3.78 | Upgrade
|
EV/EBITDA Ratio | 14.20 | 9.50 | 8.01 | 12.27 | 12.83 | 11.85 | Upgrade
|
EV/EBIT Ratio | 15.79 | 10.74 | 9.29 | 14.50 | 16.04 | 16.63 | Upgrade
|
EV/FCF Ratio | 22.31 | 18.74 | 14.53 | 17.05 | -223.96 | 32.73 | Upgrade
|
Debt / Equity Ratio | 0.07 | 0.07 | 0.18 | 0.20 | 0.12 | 0.09 | Upgrade
|
Debt / EBITDA Ratio | 0.30 | 0.33 | 0.87 | 1.06 | 0.78 | 0.78 | Upgrade
|
Debt / FCF Ratio | 0.44 | 0.65 | 1.58 | 1.47 | -13.54 | 2.16 | Upgrade
|
Asset Turnover | 0.54 | 0.52 | 0.43 | 0.41 | 0.37 | 0.32 | Upgrade
|
Inventory Turnover | 1.81 | 1.89 | 2.55 | 2.40 | 2.07 | 2.58 | Upgrade
|
Quick Ratio | 2.85 | 2.96 | 4.04 | 3.86 | 2.87 | 4.82 | Upgrade
|
Current Ratio | 3.68 | 3.89 | 4.56 | 4.31 | 3.55 | 5.62 | Upgrade
|
Return on Equity (ROE) | 19.64% | 18.53% | 12.41% | 15.80% | 13.17% | 6.64% | Upgrade
|
Return on Assets (ROA) | 11.91% | 11.38% | 9.10% | 8.78% | 7.08% | 4.51% | Upgrade
|
Return on Capital (ROIC) | 13.02% | 12.33% | 9.90% | 9.50% | 7.65% | 4.88% | Upgrade
|
Earnings Yield | 4.48% | 6.85% | 5.82% | 5.71% | 5.94% | 4.85% | Upgrade
|
FCF Yield | 4.15% | 4.73% | 6.04% | 5.46% | -0.43% | 2.82% | Upgrade
|
Dividend Yield | 0.50% | 0.87% | 0.95% | 0.75% | 0.90% | 0.85% | Upgrade
|
Payout Ratio | 11.54% | 9.84% | 15.56% | 10.77% | 9.05% | 17.84% | Upgrade
|
Buyback Yield / Dilution | -11.98% | -5.85% | 0.76% | -5.74% | -0.73% | 3.54% | Upgrade
|
Total Shareholder Return | -11.48% | -4.98% | 1.72% | -5.00% | 0.17% | 4.39% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.